GE HealthCare Recommends Shareholders Reject "Mini-Tender" Offer by Potemkin Limited
Business Wire (Tue, 6-Jan 5:00 PM ET)
NXP and GE HealthCare Accelerate AI Innovation in Acute Care
Globe Newswire (Tue, 6-Jan 11:00 AM ET)
GE HealthCare to announce fourth quarter and full year 2025 results on February 4, 2026
Business Wire (Mon, 5-Jan 8:00 AM ET)
GE HealthCare management to present at upcoming investor conference
Business Wire (Mon, 29-Dec 8:00 AM ET)
Vaso Corporation Announces Fifth Extension of Sales Representation Agreement with GE HealthCare
Globe Newswire (Wed, 17-Dec 9:00 AM ET)
Business Wire (Tue, 16-Dec 9:00 PM ET)
Global AI Infrastructure Shift Ignites Biotech Growth Phase
Globe Newswire (Tue, 9-Dec 9:25 AM ET)
Business Wire (Wed, 3-Dec 1:00 PM ET)
Business Wire (Wed, 3-Dec 9:00 AM ET)
Business Wire (Tue, 2-Dec 9:00 AM ET)
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
Ge Healthcare Techs trades on the NASDAQ stock market under the symbol GEHC.
As of January 26, 2026, GEHC stock price climbed to $80.27 with 2,303,356 million shares trading.
GEHC has a beta of 1.91, meaning it tends to be more sensitive to market movements. GEHC has a correlation of 0.68 to the broad based SPY ETF.
GEHC has a market cap of $36.56 billion. This is considered a Large Cap stock.
Last quarter Ge Healthcare Techs reported $5 billion in Revenue and $1.07 earnings per share. This beat revenue expectation by $68 million and exceeded earnings estimates by $.02.
In the last 3 years, GEHC traded as high as $94.80 and as low as $57.65.
The top ETF exchange traded funds that GEHC belongs to (by Net Assets): VTI, VOO, QQQ, VO, IVV.
GEHC has underperformed the market in the last year with a price return of -8.8% while the SPY ETF gained +14.8%. However, in the short term, GEHC had mixed performance relative to the market. It has outperformed in the last 3 months, returning +4.0% vs +3.4% return in SPY. But in the last 2 weeks, GEHC shares have been beat by the market, returning -8.0% compared to an SPY return of -0.2%.
GEHC support price is $78.24 and resistance is $81.30 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that GEHC shares will trade within this expected range on the day.